Qube Research & Technologies LTD Axsome Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 391,617 shares of AXSM stock, worth $52.8 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
391,617
Previous 282,376
38.69%
Holding current value
$52.8 Million
Previous $32.9 Million
24.13%
% of portfolio
0.04%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding AXSM
# of Institutions
413Shares Held
37.4MCall Options Held
710KPut Options Held
541K-
Vanguard Group Inc Valley Forge, PA3.95MShares$532 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$445 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$228 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$205 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$154 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.79B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...